These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3019897)

  • 1. [Inhibition of gyrase by 4-quinolones: effect on the structure of DNA].
    Weisser J; Wiedemann B
    Infection; 1986; 14 Suppl 3():S183-5. PubMed ID: 3019897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-quinolones and the physiology of DNA gyrase.
    Drlica K; Kreiswirth B
    Adv Pharmacol; 1994; 29A():263-83. PubMed ID: 7826862
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinolones: pharmacology.
    Verbist L
    Pharm Weekbl Sci; 1986 Feb; 8(1):22-5. PubMed ID: 3008075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of the new quinolones: new data.
    Hooper DC; Wolfson JS
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):223-31. PubMed ID: 1650698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.
    Hoshino K; Sato K; Une T; Osada Y
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1816-8. PubMed ID: 2556080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo.
    Pohlhaus JR; Kreuzer KN
    Mol Microbiol; 2005 Jun; 56(6):1416-29. PubMed ID: 15916595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in DNA gyrase inhibitors.
    Kim OK; Ohemeng K; Barrett JF
    Expert Opin Investig Drugs; 2001 Feb; 10(2):199-212. PubMed ID: 11178337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
    Hooper DC
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S54-63. PubMed ID: 9710672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine.
    Funatsuki K; Tanaka R; Inagaki S; Konno H; Katoh K; Nakamura H
    Biol Pharm Bull; 1998 Jul; 21(7):667-72. PubMed ID: 9703246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of DNA gyrase inhibition by quinolone antibacterials.
    Shen LL
    Adv Pharmacol; 1994; 29A():285-304. PubMed ID: 7826863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.
    Onodera Y; Tanaka M; Sato K
    J Antimicrob Chemother; 2001 Apr; 47(4):447-50. PubMed ID: 11266418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG; Barnard FM; Wentzell LM; Maxwell A
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.
    Zhao X; Xu C; Domagala J; Drlica K
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13991-6. PubMed ID: 9391140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ofloxacin, a bactericidal antibacterial.
    Smith JT
    Chemotherapy; 1991; 37 Suppl 1():2-13. PubMed ID: 1646700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA gyrase as a drug target.
    Maxwell A
    Biochem Soc Trans; 1999 Feb; 27(2):48-53. PubMed ID: 10093705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.